Future studies must be conducted to further analyze if levels of salivary total α-synuclein, oligomeric α-synuclein, DJ-1 protein, and other potential markers can be used as salivary biomarkers not only to detect PD but to also determine the severity and differentiate between the various stages of PD. The gene discussed is SNCA; the disease is Parkinson disease.